Home > Boards > US Listed > Biotechs >

Portola Phramaceuticals (PTLA)

PTLA RSS Feed
Add PTLA Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/6/2020 1:18:58 AM - Followers: 23 - Board type: Free - Posts Today: 0
PTLA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PTLA News: Termination of Registration of a Class of Security Under Section 12(b) (15-12b) 07/13/2020 08:30:49 AM
PTLA News: Statement of Changes in Beneficial Ownership (4) 07/07/2020 03:40:31 PM
PTLA News: Statement of Changes in Beneficial Ownership (4) 07/02/2020 05:56:35 PM
PTLA News: Statement of Changes in Beneficial Ownership (4) 07/02/2020 05:55:30 PM
PTLA News: Statement of Changes in Beneficial Ownership (4) 07/02/2020 05:46:03 PM
PostSubject
#196   That's why he is not your boss. TrendVestor 05/06/20 01:18:58 AM
#195   So I was off by a few bucks. NYCPuglet 05/05/20 09:56:12 AM
#194   It was only between 20-40 then europtiger 05/05/20 09:46:21 AM
#193   My jackass boss told everyone in 2018 to NYCPuglet 01/30/20 11:41:13 AM
#192   New SoS post: H2R 01/10/20 05:28:53 PM
#191   * * $PTLA Video Chart 01-10-2020 * * ClayTrader 01/10/20 05:19:54 PM
#190   PTLA -40% on soft 4Q19 Andexxa sales—consistent with DewDiligence 01/10/20 05:13:52 PM
#189   A disappointing quarter! H2R 01/10/20 11:08:06 AM
#188   News: $PTLA Portola Pharmaceuticals Presents New Interim Data whytestocks 12/08/19 12:30:33 PM
#187   Updated Smith on Stocks Projection H2R 11/08/19 04:31:28 PM
#186   LOL re the Bevyxxa sales figure. DewDiligence 11/05/19 06:02:00 PM
#185   Smith on Stock August projection is close to H2R 11/05/19 05:52:44 PM
#184   Q3 2019: $36.8M v. $14.2 M Q3 2018! H2R 11/05/19 05:49:44 PM
#183   EPS beats by $0.34, beats on revenue H2R 11/05/19 05:47:31 PM
#182   Sales have started, but they're rather anemic. DewDiligence 09/02/19 07:44:26 PM
#181   How could we miss with this company? heyyou2 09/02/19 07:18:34 PM
#180   Ptla has gone lazy as of late...good earnings..good ACTcrazy 08/22/19 11:34:41 AM
#178   Nice, late on a Friday news! Monday will ACTcrazy 04/27/19 12:31:45 AM
#177   Europe conditional Marketing Authorization for Ondexxya™ H2R 04/26/19 05:11:48 PM
#176   Buying oppurtunity? Slow drift on no news. Almost May....Glta. ACTcrazy 04/15/19 09:56:46 PM
#175   Slow steady accumulation with modest rise past three ACTcrazy 03/30/19 12:15:59 AM
#174   Solid value for the PPS action today. H2R 03/01/19 05:20:47 PM
#173   I agree ACTcrazy. H2R 03/01/19 11:33:28 AM
#172   If all goes well in May...clear the launch ACTcrazy 03/01/19 11:26:23 AM
#171   And PTLA beats on revenue! H2R 03/01/19 10:17:01 AM
#170   Thanks ACTcrazy :) H2R 03/01/19 10:14:32 AM
#169   CHMP Aproval to market Let's call this a ACTcrazy 03/01/19 09:14:33 AM
#168   Maybe in the morning? The time has come ACTcrazy 03/01/19 02:28:18 AM
#167   I don't see any news on the CHMP H2R 02/28/19 06:43:18 PM
#166   Feb 28 coming up! H2R 02/23/19 04:41:00 PM
#165   SoS on Andexxa ANNEX4-A Study: H2R 02/13/19 03:52:09 PM
#164   Positive Hemostasis in 82 Percent of Evaluable Patients H2R 02/07/19 04:09:30 PM
#163   Hi NOLA70124, H2R 01/02/19 06:14:59 PM
#162   H2R - There were ~17M shares short as NOLA70124 12/31/18 04:35:08 PM
#161   Up %14 on an above average 2.5M shares H2R 12/31/18 04:05:14 PM
#160   PTLA will target a large number of hospitals H2R 12/31/18 04:00:40 PM
#159   "PAS" APPROVED ! H2R 12/31/18 03:44:17 PM
#158   Trading halt on pending news... H2R 12/31/18 02:51:59 PM
#157   Today is the PDUFA date... Wondering how it H2R 12/31/18 02:48:44 PM
#156   PTLA getting ready for the PDUFA - December H2R 12/19/18 03:29:39 PM
#155   AMAG acquires Perosphere Pharmaceuticals—owner of FXa antidote in development: DewDiligence 12/13/18 08:13:19 AM
#154   PR from PTLA: H2R 12/12/18 01:54:21 PM
#153   Well, CHMP chickened out. No pop, but heyyou2 12/11/18 09:46:14 PM
#152   Interesting comment on SA's H2R 12/04/18 10:46:35 AM
#151   I would not be surprised if there is Valsartan160 11/17/18 03:25:59 AM
#150   A couple of notes from the CC: H2R 11/08/18 12:10:24 PM
#149   From the PR H2R 11/07/18 09:59:29 PM
#148   was this a key day? Valsartan160 10/31/18 12:21:49 AM
#147   Cerdulatinib Orphan Drug Designation H2R 09/25/18 05:53:07 PM
#146   PTLA hires CEO—former CEO at RLYP: DewDiligence 09/20/18 11:49:57 AM
PostSubject
Consent Preferences